News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ophthotech Corporation (OPHT) Announces Pricing Of Public Offering Of Common Stock


2/12/2014 8:17:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (NASDAQ:OPHT) announced today the pricing of an underwritten public offering of 2,285,714 shares of common stock at a public offering price of $31.50 per share, before underwriting discounts. Of the shares in the offering, 1,900,000 shares are being sold by Ophthotech, and 385,714 shares are being sold by certain stockholders of the company. In addition, these selling stockholders have granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 342,857 shares of the company’s common stock at the public offering price, less the underwriting discount. Ophthotech will not receive any proceeds from the sale of shares by the selling stockholders.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES